iCoreConnect Inc. (NASDAQ:ICCT) Sees Large Increase in Short Interest

iCoreConnect Inc. (NASDAQ:ICCT) was the recipient of a significant growth in short interest in March. As of March 31st, there was short interest totalling 374,600 shares, a growth of 822.7% from the March 15th total of 40,600 shares. Based on an average trading volume of 15,360,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 22.3% of the company’s stock are short sold.

iCoreConnect Price Performance

ICCT traded down $0.14 during trading on Monday, hitting $3.87. The company’s stock had a trading volume of 2,032,965 shares, compared to its average volume of 4,186,599. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 7.93. The firm has a market capitalization of $8.02 million, a price-to-earnings ratio of -0.06 and a beta of -0.69. The business’s fifty day simple moving average is $1.81 and its 200 day simple moving average is $3.28. iCoreConnect has a twelve month low of $0.24 and a twelve month high of $27.80.

Hedge Funds Weigh In On iCoreConnect

A hedge fund recently bought a new stake in iCoreConnect stock. Virtu Financial LLC purchased a new position in shares of iCoreConnect Inc. (NASDAQ:ICCT) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 12,698 shares of the company’s stock, valued at approximately $32,000. Virtu Financial LLC owned approximately 1.04% of iCoreConnect as of its most recent SEC filing. 13.42% of the stock is currently owned by hedge funds and other institutional investors.

iCoreConnect Company Profile

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.